Earnings Preview: Boston Scientific

Hewlett Packard (HPQ)

Dell (DELL)

Facebook (FB)

Apple (AAPL)

Goldman Sachs (GS)

Fred's First Quarter 2012 EPS Increase 17%

Newell Rubbermaid to Reaffirm Fiscal Year 2012 Outlook

Best ETFs For Facebook Exposure

McDonald's Announces Quarterly Cash Dividend

Is KB HOME Closing in to Resistance?

Earnings Preview: Boston Scientific

Published on Wednesday, 01 February 2012 10:36 Written by Christopher Lynn

bsx New York, February 1st (TradersHuddle.com) - Shares of Boston Scientific Corporation (NYSE:BSX) are trading higher by +3.69% ahead of its quarterly earnings release. Boston Scientific, the heart stent maker is expected to release its quarterly results on January 2^nd.

Wall Street Analysts consensus calls for a profit of $0.08 a share on $1.91 billion revenue.

Boston Scientific estimates have a range of $0.04 a share. The high estimate calls for profit of $0.1 a share and the low estimate is calling for a profit of $0.06 a share, a year ago for the quarter the company reported $0.12 a share.

Boston Scientific Corporation (NYSE:BSX) develops, manufactures, and markets minimally invasive medical device, which are used in interventional cardiology, cardiac rhythm management, and peripheral interventions, mong others.

Other companies on the watch on this earnings event are Johnson and Johnson NYSE:JNJ and St. Jude Medical, Inc. NYSE:STJ.

Real Money Pro from TheStreet: Headlined by legendary hedge fund manager Doug Kass, our team of market technicians and professional traders hand you unique perspectives and breakthrough investment opportunities. Access this exciting service -- Real Money Pro -- FREE, right now!